Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1980 Jul 19;123(2):128–129.

Reinstitution of allopurinol therapy for gouty arthritis after cutaneous reactions.

A G Fam, T W Paton, A Chaiton
PMCID: PMC1704657  PMID: 6455189

Full text

PDF
128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boss G. R., Seegmiller J. E. Hyperuricemia and gout. Classification, complications and management. N Engl J Med. 1979 Jun 28;300(26):1459–1468. doi: 10.1056/NEJM197906283002604. [DOI] [PubMed] [Google Scholar]
  2. Kantor G. L. Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy. JAMA. 1970 Apr 20;212(3):478–479. [PubMed] [Google Scholar]
  3. Meyrier A. Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol. Br Med J. 1976 Aug 21;2(6033):458–458. doi: 10.1136/bmj.2.6033.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Rundles R. W., Metz E. N., Silberman H. R. Allopurinol in the treatment of gout. Ann Intern Med. 1966 Feb;64(2):229–258. doi: 10.7326/0003-4819-64-2-229. [DOI] [PubMed] [Google Scholar]
  5. Wilson J. D., Simmonds H. A., North J. D. Allopurinol in the treatment of uraemic patients with gout. Ann Rheum Dis. 1967 Mar;26(2):136–142. doi: 10.1136/ard.26.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES